Antibe Therapeutics’ Lead Drug Shows Promising Effects in Alveolar Bone Loss Study - Press Release
Digital Journal,
TORONTO--(Business Wire)--Antibe Therapeutics Inc. ("Antibe" or the "Company") (TSXV: ATE, OTCQX: ATBPF) is pleased to announce…
Antibe Therapeutics’ Lead Drug Shows Promising Effects in Alveolar Bone Loss Study
CNBC,
These results open up potential uses of Antibe’s drug candidates in the fields of regenerative medicine, orthopaedic and…
Antibe Therapeutics Inc.??? Lead Drug Shows Promising Effects In Alveolar Bone Loss Study
Biospace,
TORONTO--( BUSINESS WIRE )--Antibe Therapeutics Inc. ("Antibe" or the "Company") (TSXV: ATE, OTCQX: ATBPF) is pleased to…